Isavuconazole treatment for fungal disease in leukemia patients
Is venetoclax appropriate for relapsed CLL patients?
The future of lymphoma treatment – combining new therapies with molecular diagnosis
The importance of anti-CD38 monoclonal antibodies for multiple myeloma
Comparing continuous and fixed duration myeloma treatment with triplets and doublets